SEC Form 13F
| Report period | 2025-09-30 |
|---|---|
| Publicly available | 2025-11-04 |
| Reported value | $29,373,266 |
| Positions | 2 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| KYVERNA THERAPEUTICS INC | KYTX | COM | $27,143,544 | 4,523,924 |
| ALLOGENE THERAPEUTICS INC | ALLO | COM | $2,229,722 | 1,798,163 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.